18 days ago
ABOS
AnalystsGeoff MeachamGeoff Meacham's Stock Forecasts
AnalystsGeoff Meacham
Analyst Ranking
Top 7%
#345 out of 5527 analysts
Average Return
+11.28%
Win Rate
57%121 out of 213
Risk vs Reward
Poor
Good
Geoff Meacham's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Amylyx Pharmaceuticals IncAMLX | +294.69% | $9.42 | $37.18 | 2025-08-28 - 2026-08-27 | Strong Buy |
Amylyx Pharmaceuticals IncAMLX | +182.36% | $5.33 | $15.05 | 2025-06-17 - 2026-06-16 | Strong Buy |
Bridgebio Pharma IncBBIO | +161.09% | $27.19 | $70.99 | 2024-11-25 - 2025-11-24 | Strong Buy |
Veradermics IncMANE | +151.44% | $46.62 | $117.22 | 2026-03-02 - 2026-10-01 | Strong Buy |
Coherent CorpCOHR | +150.48% | $26.29 | $65.85 | 2020-03-23 - 2021-03-23 | Strong Buy |
Geoff Meacham Analyst Color
Get additional color on Geoff Meacham's coverage of popular stocks
19 days ago
SRRK
a month ago
PTGX
2 months ago
BBIO
2 months ago
PTGX
2 months ago
AMLX
2 months ago
BMY
2 months ago
KNSA
3 months ago
MANE
3 months ago
LLY
3 months ago
ABBV
4 months ago
TYRA
4 months ago
PTCT
5 months ago
RPRX
6 months ago
MGTX
6 months ago
APGE
6 months ago
PTGX
7 months ago
VRTX
7 months ago
SRRK
7 months ago
AMLX
8 months ago
MRK
8 months ago
GILD
8 months ago
MRK
8 months ago
RPRX
10 months ago
PTGX
Geoff Meacham's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Jazz Pharmaceuticals PLCJAZZ | 1 | Strong Buy | $325.00 | +39.48% | Initiates Coverage On | 3 days ago |
Moderna IncMRNA | 10 | Strong Sell | $80.00 | -57.66% | Downgrades | 3 days ago |
Nuvation Bio IncNUVB | 1 | Strong Buy | $12.00 | +115.83% | Initiates Coverage On | 3 days ago |
Acumen Pharmaceuticals IncABOS | 7 | Strong Buy | $5.00 | +141.55% | Maintains | 18 days ago |
Scholar Rock Holding CorpSRRK | 4 | Strong Buy | $74.00 | +60.31% | Maintains | 19 days ago |
Protagonist Therapeutics IncPTGX | 8 | Strong Buy | $182.00 | +30.76% | Maintains | a month ago |
Bridgebio Pharma IncBBIO | 7 | Strong Buy | $104.00 | +55.43% | Maintains | 2 months ago |
Amgen IncAMGN | 13 | Hold | $405.00 | -0.56% | Maintains | 2 months ago |
Biontech SeBNTX | 4 | Strong Buy | $125.00 | +29.07% | Maintains | 2 months ago |
Amylyx Pharmaceuticals IncAMLX | 7 | Strong Buy | $26.00 | -7.41% | Maintains | 2 months ago |
Regeneron Pharmaceuticals IncREGN | 13 | Hold | $740.00 | +0.71% | Maintains | 2 months ago |
Bristol Myers Squibb CoBMY | 9 | Hold | $70.00 | +13.90% | Maintains | 2 months ago |
Biogen IncBIIB | 20 | Hold | $215.00 | -3.51% | Maintains | 2 months ago |
Kiniksa Pharmaceuticals International PLCKNSA | 6 | Strong Buy | $100.00 | +32.94% | Maintains | 2 months ago |
Veradermics IncMANE | 3 | Strong Buy | $160.00 | +36.50% | Maintains | 3 months ago |
Eli Lilly & CoLLY | 11 | Strong Buy | $1,600.00 | +39.15% | Maintains | 3 months ago |
Abbvie IncABBV | 24 | Hold | $260.00 | +0.03% | Maintains | 3 months ago |
Apogee Therapeutics IncAPGE | 4 | Hold | $135.00 | -0.05% | Downgrades | 3 months ago |
Tyra Biosciences IncTYRA | 3 | Strong Buy | $42.00 | +99.90% | Maintains | 4 months ago |
Ptc Therapeutics IncPTCT | 11 | Strong Buy | $108.00 | +68.41% | Assumes | 4 months ago |
Regenxbio IncRGNX | 2 | Strong Buy | $14.00 | +88.68% | Maintains | 5 months ago |
Royalty Pharma PLCRPRX | 5 | Strong Buy | $66.00 | +14.52% | Maintains | 5 months ago |
Merck & Co IncMRK | 13 | Hold | $125.00 | -13.08% | Reinstates | 5 months ago |
Pfizer IncPFE | 8 | Hold | $27.00 | -3.98% | Maintains | 5 months ago |
Gilead Sciences IncGILD | 10 | Strong Buy | $165.00 | +11.86% | Maintains | 6 months ago |
Meiragtx Holdings PLCMGTX | 2 | Strong Buy | $16.00 | +50.09% | Maintains | 6 months ago |
Biomarin Pharmaceutical IncBMRN | 4 | Strong Buy | $85.00 | +45.45% | Maintains | 7 months ago |
Vertex Pharmaceuticals IncVRTX | 6 | Strong Buy | $585.00 | +15.44% | Maintains | 7 months ago |
Kymera Therapeutics IncKYMR | 8 | Strong Buy | $120.00 | +8.97% | Maintains | 7 months ago |
Arcellx IncACLX | 2 | Hold | $115.00 | -0.06% | Downgrades | 7 months ago |
Vor Biopharma IncVOR | 1 | Strong Buy | $50.00 | +176.85% | Initiates Coverage On | 9 months ago |
Janux Therapeutics IncJANX | 3 | Strong Buy | $49.00 | +188.92% | Maintains | 10 months ago |
Avidity Biosciences IncRNAM | 8 | Hold | $72.00 | +388.14% | Downgrades | a year ago |
Newamsterdam Pharma Co NvNAMS | 2 | Strong Buy | $50.00 | +106.95% | Maintains | a year ago |
Crispr Therapeutics AgCRSP | 4 | Strong Buy | $93.00 | +67.75% | Maintains | a year ago |
Vir Biotechnology IncVIR | 3 | Strong Buy | $14.00 | N/A | Upgrades | a year ago |
Novavax IncNVAX | 1 | Strong Sell | $6.00 | N/A | Initiates Coverage On | a year ago |
Neumora Therapeutics IncNMRA | 3 | Sell | $1.00 | N/A | Downgrades | 2 years ago |
89bio IncETNB | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 2 years ago |
Bioxcel Therapeutics IncBTAIQ | 5 | Sell | $4.00 | N/A | Downgrades | 2 years ago |
Lyell Immunopharma IncLYEL | 3 | Sell | $20.00 | N/A | Downgrades | 2 years ago |
Turnstone Biologics CorpTSBX | 2 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Johnson & JohnsonJNJ | 2 | Hold | $170.00 | N/A | Maintains | 2 years ago |
LianbioLIANY | 1 | Sell | $3.00 | N/A | Downgrades | 3 years ago |
Igm Biosciences IncIGMS | 2 | Hold | $8.00 | N/A | Downgrades | 3 years ago |
Curevac NvCVAC | 4 | Sell | $8.00 | N/A | Maintains | 3 years ago |
Rani Therapeutics Holdings IncRANI | 1 | Strong Buy | $17.00 | N/A | Maintains | 3 years ago |
Intercept Pharmaceuticals IncICPT | 5 | Sell | $14.00 | N/A | Maintains | 3 years ago |
Lenz Therapeutics IncLENZ | 3 | Sell | $2.00 | N/A | Downgrades | 4 years ago |
Inovio Pharmaceuticals IncINO | 4 | Sell | $24.00 | N/A | Downgrades | 4 years ago |
Omeros CorpOMER | 2 | Hold | $4.00 | N/A | Downgrades | 4 years ago |
Vaxxinity IncVAXX | 1 | Strong Buy | $21.00 | N/A | Initiates Coverage On | 5 years ago |
Checkmate Pharmaceuticals IncCMPI | 1 | Strong Buy | $7.00 | N/A | Upgrades | 5 years ago |
Erasca IncERAS | 1 | Strong Buy | $28.00 | N/A | Initiates Coverage On | 5 years ago |
Century Therapeutics IncIPSC | 1 | Strong Buy | $34.00 | N/A | Initiates Coverage On | 5 years ago |
Y Mabs Therapeutics IncYMAB | 3 | Strong Buy | $56.00 | N/A | Upgrades | 5 years ago |
Esperion Therapeutics IncESPR | 2 | Hold | $35.00 | N/A | Downgrades | 6 years ago |
Seagen IncSGEN | 6 | Strong Buy | N/A | N/A | Upgrades | 6 years ago |
Damora Therapeutics IncDMRA | 1 | Strong Buy | $525.00 | N/A | Initiates Coverage On | 6 years ago |
Pmv Pharmaceuticals IncPMVP | 1 | Strong Buy | $42.00 | N/A | Initiates Coverage On | 6 years ago |
Sangamo Therapeutics IncSGMO | 1 | Strong Buy | $20.00 | N/A | Reinstates | 6 years ago |
Poseida Therapeutics IncPSTX | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 6 years ago |
Puma Biotechnology IncPBYI | 1 | Sell | $9.00 | N/A | Reinstates | 6 years ago |
Genfit SaGNFTY | 1 | Sell | $7.00 | N/A | Initiates Coverage On | 6 years ago |
Eidos Therapeutics IncEIDX | 1 | Hold | $51.00 | N/A | Initiates Coverage On | 7 years ago |
Coherent CorpCOHR | 1 | Strong Buy | $31.00 | N/A | Initiates Coverage On | 7 years ago |
Alexion Pharmaceuticals IncALXN | 1 | Hold | $110.00 | N/A | Downgrades | 7 years ago |
United Therapeutics CorpUTHR | 2 | Strong Sell | $95.00 | N/A | Maintains | 8 years ago |
Myovant Sciences LtdMYOV | 2 | Strong Buy | $25.00 | N/A | Upgrades | 8 years ago |
Dbv Technologies SaDBVT | 3 | Hold | $80.00 | N/A | Downgrades | 8 years ago |
Gritstone Bio IncGRTSQ | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 8 years ago |
Neurocrine Biosciences IncNBIX | 2 | Strong Buy | $135.00 | N/A | Maintains | 8 years ago |
Prothena Corp Public Ltd CoPRTA | 2 | Strong Sell | N/A | N/A | Downgrades | 8 years ago |
Zymeworks IncZYME | 2 | Hold | N/A | N/A | Upgrades | 8 years ago |
Ironwood Pharmaceuticals IncIRWD | 1 | Hold | $20.00 | N/A | Maintains | 8 years ago |
Incyte CorpINCY | 2 | Strong Buy | $135.00 | N/A | Maintains | 8 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 2 | Hold | N/A | N/A | Downgrades | 8 years ago |
Acceleron Pharma IncXLRN | 2 | Strong Buy | $54.00 | N/A | Maintains | 9 years ago |
Celgene CorpCELG | 4 | Strong Buy | N/A | N/A | Upgrades | 9 years ago |
Alnylam Pharmaceuticals IncALNY | 4 | Strong Buy | $158.00 | N/A | Maintains | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.